Saturday, February 16, 2019

New York Times Editorial Advocates for Policies that Could Hurt Patients

In an editorial published on Friday, June 8, 2018, in The New York Times (Easier Drug Approval Isn’t Cutting Drug Prices), the Times Editorial Board claims that the U.S. Food and Drug Administration (FDA) is lowering standards by working to get treatments to patients more quickly and instituting a less regulation approach to reviewing new drugs and medical devices. The...

A Key-Hole View on Healthcare Disparity

The topic of healthcare disparity has been discussed in many forums and many articles have been written to bring about awareness, debate the issue, find fault in the system, and make assumptions on what the right solution is.  I am, by no means, an expert on this topic but I believe that healthcare economic burdens are paramount everywhere. Patients experience substantial...

Immunotherapy’s Promise for Lung Cancer Treatment

Cancer research is often defined by slow, incremental progress, building upon years, often decades, of previous discoveries. Then if we get lucky, someone figures out something that adds jet fuel to the process, propelling the entire field forward with new energy and new optimism. As chief of oncology at Yale and having cared for lung cancer patients for the...

Three Pillars of Psycho-social Support for Children of a Parent with Cancer

“Life without a mother – how would that be? A year in which we would all define what love really meant, how tight our family really was, and soon after… how easily everything could fall apart. It was going to be the year I had to start taking care of myself, and grow into maturity – even though I...

Eric Rosenthal Reports | A Personal Remembrance of Two Giants of Oncology: Jim and Jimmie Holland

James F. Holland, MD, one of the pioneers of combination chemotherapy and cancer cooperative group research, died at the age of 92 on March 22. His wife, Jimmie C. Holland, MD, who was considered the founder of psycho-oncology, predeceased him by three months on Christmas Eve at age 89. Jim was Distinguished Professor of Neoplastic Diseases at the Icahn School...

The Onco’Zine Brief – Broadening the Understanding of Cancer and Cancer Treatment

Cancer Kills. With more than 8.2 million deaths in 2012, it is the second leading cause of death globally. In addition, the economic impact of cancer is significant and is increasing. That same year there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis). Further, the...

An end to Smoking: Tackling the Leading Cause of Preventable Disease and Premature Death

According to the latest data from the Office of Smoking and Health of the U.S. Centers for Disease Control and Prevention, almost 90% of all adult smokers started smoking before the age of 18, and each day in the U.S., nearly 2,500 young people smoke their first cigarette. The relative young age in which many smokers begin smoking...

The Power of The Immune System

Earlier this month, in The Onco’Zine Brief, our weekly radio broadcast and podcast, Sonia Portillo and I interviewed Joshua A. Hill, MD, an Associate in the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center in Seattle, Washington and an attending physician at the Seattle Cancer Care Alliance, as well as an Assistant Professor at the University...

Physicians Sue over Monopolistic “Maintenance of Certification”

Before 1990, American physicians who had completed 3 years or more of rigorous training in a specialty and passed an examination were awarded lifetime “board certification.” The only exception was the family practice board, which has always issued only time-limited certificates. After 1990, all member boards of the American Board of Medical Specialties (ABMS) followed suit and the nightmare...

Can Corporate Heavyweights Really Tackle the Healthcare Issue?

Three of the most respected corporations in America announced plans this week to start a new company to tackle rising healthcare costs. The three companies – Amazon, Berkshire Hathaway and JP Morgan Chase – are dominant in their respect business sectors and their chief executives – Jeff Bezos, Warren Buffett and Jamie Dimon, respectively - are true corporate rock...

right side

ads

Related articles